Luxna Biotech Co.
Latest round
- Series C
Last raised
- Aug 2025
Total raised
- $20M
Investors
- 14
About Luxna Biotech Co.
, Ltd. engages in the nucleic acid editing business. The firm also engages in drug creation, such as oligonucleotide therapeutics, and cancer research. The company develops nucleic acid drugs using artificial nucleic acids with pharmaceutical and chemical companies. Nucleic acid medicines utilize DNA and RNA molecules to treat diseases. These therapies have the potential to revolutionize treatment options for conditions such as genetic disorders and cancers by harnessing the body’s biological mechanisms. In? August 2025,?,Ltd.
Who invested in Luxna Biotech Co.
14 investors across 5 rounds
See all investors in Luxna Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Luxna Biotech Co.
Who invested in Luxna Biotech Co.?
Luxna Biotech Co. has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Luxna Biotech Co. raised?
Luxna Biotech Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Luxna Biotech Co. last raise money?
Luxna Biotech Co.'s most recent round on record is a Series C, in Aug 2025.
What does Luxna Biotech Co. do?
Luxna Biotech Co. is a biotechnology company.
Where is Luxna Biotech Co. headquartered?
Luxna Biotech Co. is headquartered in Suita-shi, Japan.
Which VCs invest in companies like Luxna Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Luxna Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Luxna Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.